{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:45:03Z","timestamp":1782783903593,"version":"3.54.5"},"reference-count":27,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Ankylosing Spondylitis (AS) is a chronic inflammatory autoimmune rheumatic disease that primarily affects the spine and sacroiliac joints. This study aimed to investigate the expression levels of immune response-related genes, including IRF7, NFKB1A, TNFAIP3, STAT1, TRIM21, TRIM22, and TRIM25, as well as the serum levels of CXCL10 and SIRPA proteins in patients with AS. In addition, the potential diagnostic performance of these molecular and serum biomarkers in distinguishing patients with AS from healthy controls was evaluated. A total of 45 patients with AS and 44 healthy controls were included in the study. Immune-related gene expression levels were analyzed using RT-PCR. In addition, serum CXCL10 and SIRPA protein levels were evaluated using ELISA. The expression levels of NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21 were significantly increased in patients with AS compared to healthy controls (p &lt; 0.05). In contrast, no significant differences were detected in the expression levels of TRIM22 and TRIM25. In the ROC analysis, the highest diagnostic performance was obtained for NFKB1A (AUC = 0.741), TNFAIP3 (AUC = 0.720), and TRIM21 (AUC = 0.722). Serum CXCL10 and SIRPA levels were not significantly different between the groups. In AS, genes particularly associated with NF-\u03baB and interferon signaling pathways (NFKB1A, TNFAIP3, IRF7, STAT1, and TRIM21) were found to be significantly altered, and these genes may serve as potential molecular biomarkers for AS. In contrast, the diagnostic power of serum protein biomarkers is limited. These findings indicate that the potential of these genes as biomarkers for AS pathogenesis should be further supported by advanced studies evaluating their expression levels.<\/jats:p>","DOI":"10.3390\/ijms27135823","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:55:11Z","timestamp":1782780911000},"page":"5823","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune Regulatory Endotypes Defined by TRIM-Dependent Ubiquitin Signaling and IFN\u2013NF-\u03baB Network Activity in Ankylosing Spondylitis"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1570-8848","authenticated-orcid":false,"given":"Sevil Ceyhan","family":"Dogan","sequence":"first","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tugba","family":"Agbektas","sequence":"additional","affiliation":[{"name":"Department of Food Processing Technologies, Y\u0131ld\u0131zeli Vocational School, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6713-5888","authenticated-orcid":false,"given":"Mert","family":"Atas","sequence":"additional","affiliation":[{"name":"Department of Physical Medicine and Rehabilitation, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonca","family":"Kabak","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7132-1325","authenticated-orcid":false,"given":"Ayca","family":"Tas","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yavuz","family":"Silig","sequence":"additional","affiliation":[{"name":"Department of Medical Biochemistry, Faculty of Medicine, Sivas Cumhuriyet University, Sivas 58140, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","article-title":"Ankylosing spondylitis","volume":"369","author":"Braun","year":"2007","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrrheum.2015.133","article-title":"Genetics of ankylosing spondylitis","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1146\/annurev.immunol.021908.132641","article-title":"Regulation and function of NF-\u03baB transcription factors in the immune system","volume":"27","author":"Vallabhapurapu","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nri2413","article-title":"TRIM family proteins and their emerging roles in innate immunity","volume":"8","author":"Ozato","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/s41467-025-60445-6","article-title":"Type 1 interferon signature and allograft inflammatory factor-1 contribute to refractoriness to TNF inhibition in ankylosing spondylitis","volume":"16","author":"Song","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_7","first-page":"87","article-title":"Interferon-linked lipid and bile acid imbalance uncovered in ankylosing spondylitis in a sibling-controlled multi-omics study","volume":"15","author":"Wang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nri3787","article-title":"Type I interferons in infectious disease","volume":"15","author":"McNab","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/nature05732","article-title":"TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity","volume":"446","author":"Gack","year":"2007","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nature03464","article-title":"IRF-7 is the master regulator of type-I interferon-dependent immune responses","volume":"434","author":"Honda","year":"2005","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-\u03baB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri3313","article-title":"A20: Linking a complex regulator of ubiquitylation to immunity and human disease","volume":"12","author":"Ma","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"ref_13","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1146\/annurev-immunol-032713-120142","article-title":"The interaction between signal regulatory protein alpha (SIRP\u03b1) and CD47: Structure, function, and therapeutic target","volume":"32","author":"Barclay","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sode, J., Bank, S., Vogel, U., Andersen, P.S., S\u00f8rensen, S.B., Bojesen, A.B., Andersen, M.R., Brandslund, I., Dessau, R.B., and Hoffmann, H.J. (2018). Genetically determined high activities of the TNF-alpha, IL23\/IL17, and NFkB pathways were associated with increased risk of ankylosing spondylitis. BMC Med. Genet., 19.","DOI":"10.1186\/s12881-018-0680-z"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yu, H.C., Huang, K.Y., Lu, M.C., Huang Tseng, H.Y., Liu, S.Q., Lai, N.S., and Huang, H.B. (2021). Down-regulation of LOC645166 in T cells of ankylosing spondylitis patients promotes the NF-\u03baB signaling via decreasingly blocking recruitment of the IKK complex to K63-linked polyubiquitin chains. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.591706"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1559325819901239","DOI":"10.1177\/1559325819901239","article-title":"miR-21 may act as a potential mediator between inflammation and abnormal bone formation in ankylosing spondylitis based on TNF-\u03b1 concentration-dependent manner through the JAK2\/STAT3 pathway","volume":"18","author":"Zou","year":"2020","journal-title":"Dose-Response"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.4049\/jimmunol.1202341","article-title":"Expression of the immune regulator tripartite-motif 21 is controlled by IFN regulatory factors","volume":"191","author":"Ambrosi","year":"2013","journal-title":"J. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","article-title":"IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+ CD4\u2212 CD8\u2212 entheseal resident T cells","volume":"18","author":"Sherlock","year":"2012","journal-title":"Nat. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s13075-018-1754-1","article-title":"Aberrant expression of interleukin-23-regulated miRNAs in T cells from patients with ankylosing spondylitis","volume":"20","author":"Lai","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Yan, S., Wang, P., Wang, J., Yang, J., Lu, H., Jin, C., Cheng, M., and Xu, D. (2019). Long non-coding RNA HIX003209 promotes inflammation by sponging miR-6089 via TLR4\/NF-\u03baB signaling pathway in rheumatoid arthritis. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02218"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaci.2022.06.008","article-title":"Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses?","volume":"150","author":"Pavlov","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/s41584-020-0450-0","article-title":"Biomarker development for axial spondyloarthritis","volume":"16","author":"Brown","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"Valkenburg","year":"1984","journal-title":"Arthritis Rheumatol."},{"key":"ref_25","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J. Rheumatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Assessment of SpondyloArthritis international Society. Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0039-6109(05)70381-9","article-title":"Measurement of pain","volume":"79","author":"Katz","year":"1999","journal-title":"Surg. Clin. N. Am."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5823\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:09:48Z","timestamp":1782781788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/13\/5823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":27,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["ijms27135823"],"URL":"https:\/\/doi.org\/10.3390\/ijms27135823","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]}}}